Scientific Literature Search

Source record

Genomewide linkage study of modifiers of LRRK2-related Parkinson's disease.

Latourelle JC, Hendricks AE, Pankratz N, Wilk JB, Halter C, Nichols WC, Gusella JF, Destefano AL, Myers RH, Foroud T, PSG-Progeni GenePD Investigators, Coordinators, and Molecular Genetic Laboratories.

Mov Disord · 2011-06-09

DOI: 10.1002/mds.23781PMID: 21661047

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Subclinical signs in LRRK2 mutation carriers.

Johansen KK, White LR, Farrer MJ, Aasly JO.

Parkinsonism Relat Disord · 2011-06-08

DOI: 10.1016/j.parkreldis.2011.04.014PMID: 21641848

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

LRRK2 directly phosphorylates Akt1 as a possible physiological substrate: impairment of the kinase activity by Parkinson's disease-associated mutations.

Ohta E, Kawakami F, Kubo M, Obata F.

FEBS Lett · 2011-06-02

DOI: 10.1016/j.febslet.2011.05.044PMID: 21658387

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Lrrk2 p.Q1111H substitution and Parkinson's disease in Latin America.

Mata IF, Wilhoite GJ, Yearout D, Bacon JA, Cornejo-Olivas M, Mazzetti P, Marca V, Ortega O, Acosta O, Cosentino C, Torres L, Medina AC, Perez-Pastene C, Díaz-Grez F, Vilariño-Güell C, Venegas P, Miranda M, Trujillo-Godoy O, Layson L, Avello R, Dieguez E, Raggio V, Micheli F, Perandones C, Alvarez V, Segura-Aguilar J, Farrer MJ, Zabetian CP, Ross OA.

Parkinsonism Relat Disord · 2011-05-31

DOI: 10.1016/j.parkreldis.2011.05.003PMID: 21632271

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Olfactory deficits and cardiac 123I-MIBG in Parkinson's disease related to the LRRK2 R1441G and G2019S mutations.

Ruiz-Martínez J, Gorostidi A, Goyenechea E, Alzualde A, Poza JJ, Rodríguez F, Bergareche A, Moreno F, López de Munain A, Martí Massó JF.

Mov Disord · 2011-05-24

DOI: 10.1002/mds.23773PMID: 21611983

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Parkinson's disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structures.

Hakimi M, Selvanantham T, Swinton E, Padmore RF, Tong Y, Kabbach G, Venderova K, Girardin SE, Bulman DE, Scherzer CR, LaVoie MJ, Gris D, Park DS, Angel JB, Shen J, Philpott DJ, Schlossmacher MG.

J Neural Transm (Vienna) · 2011-05-07

DOI: 10.1007/s00702-011-0653-2PMID: 21552986

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

WITHDRAWN: Discrimination of Parkinson-associated LRRK2 alleles by introduction of a single nucleotide mismatch into siRNA.

Wang JJ, Li QS, Li Y, Zheng YR.

Neurosci Lett · 2011-05-06

DOI: 10.1016/j.neulet.2011.04.064PMID: 21575680

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Genetic LRRK2 models of Parkinson's disease: Dissecting the pathogenic pathway and exploring clinical applications.

Yue Z, Lachenmayer ML.

Mov Disord · 2011-04-29

DOI: 10.1002/mds.23737PMID: 21538530

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

The LRRK2 R1441C mutation is more frequent than G2019S in Parkinson's disease patients from southern Italy.

Criscuolo C, De Rosa A, Guacci A, Simons EJ, Breedveld GJ, Peluso S, Volpe G, Filla A, Oostra BA, Bonifati V, De Michele G.

Mov Disord · 2011-04-29

DOI: 10.1002/mds.23735PMID: 21538529

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Gender differences in the risk of familial parkinsonism: beyond LRRK2?

Saunders-Pullman R, Stanley K, San Luciano M, Barrett MJ, Shanker V, Raymond D, Ozelius LJ, Bressman SB.

Neurosci Lett · 2011-04-12

DOI: 10.1016/j.neulet.2011.03.098PMID: 21511009

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

Models for LRRK2-Linked Parkinsonism.

Li T, Yang D, Sushchky S, Liu Z, Smith WW.

Parkinsons Dis · 2011-04-07

DOI: 10.4061/2011/942412PMID: 21603132

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Reduced content of α-synuclein in peripheral blood leukocytes of patients with LRRK2-associated Parkinson's disease.

Pchelina SN, Emelyanov AK, Yakimovskii AF, Miller DW, Shabalina IG, Drozdova AS, Schwarzman AL.

Bull Exp Biol Med · 2011-04-01

DOI: 10.1007/s10517-011-1221-3PMID: 22235415

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

1.241 articles found

Genomewide linkage study of modifiers of LRRK2-related Parkinson's disease.

Subclinical signs in LRRK2 mutation carriers.

LRRK2 directly phosphorylates Akt1 as a possible physiological substrate: impairment of the kinase activity by Parkinson's disease-associated mutations.

Lrrk2 p.Q1111H substitution and Parkinson's disease in Latin America.

Olfactory deficits and cardiac 123I-MIBG in Parkinson's disease related to the LRRK2 R1441G and G2019S mutations.

Parkinson's disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structures.

WITHDRAWN: Discrimination of Parkinson-associated LRRK2 alleles by introduction of a single nucleotide mismatch into siRNA.

Genetic LRRK2 models of Parkinson's disease: Dissecting the pathogenic pathway and exploring clinical applications.

The LRRK2 R1441C mutation is more frequent than G2019S in Parkinson's disease patients from southern Italy.

Gender differences in the risk of familial parkinsonism: beyond LRRK2?

Models for LRRK2-Linked Parkinsonism.

Reduced content of α-synuclein in peripheral blood leukocytes of patients with LRRK2-associated Parkinson's disease.

Filters